The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Day One Biopharmaceuticals (DAWN) enjoyed a strong third quarter in 2024, significantly beating top-and-bottom-line expectations driven by robust demand for cancer therapy OJEMDA. The company raised a ...
Hosted on MSN
Needham downgrades Day One Biopharmaceuticals (DAWN)
Fintel reports that on March 6, 2026, Needham downgraded their outlook for Day One Biopharmaceuticals (NasdaqGS:DAWN) from Buy to Hold. Analyst Price Forecast Suggests 11.21% Upside As of February 25, ...
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Hosted on MSN
TD Cowen initiates coverage of Day One Biopharmaceuticals (DAWN) with buy recommendation
Fintel reports that on January 13, 2026, TD Cowen initiated coverage of Day One Biopharmaceuticals (NasdaqGS:DAWN) with a Buy recommendation. Analyst Price Forecast Suggests 114.41% Upside As of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results